Skip to main content
. 2019 Dec 12;5:1–11. doi: 10.1016/j.idm.2019.12.002

Table 4.

Comparison of the infection and the costs for the optimal control vaccine formulation starting from (N1(0),I1(0),V1(0),N2(0),I2(0),V2(0))=P4=(281.87,83.23,0,2.28,2.25,0) after T=365 days.

Cases N1 I1 V1 N2 I2 V2
no treatment 281.87 83.23 2.28 2.25
u1=0.2,u2=0 333.51 0.00 284.51 2.70 1.00
u1=0,u2=0.2 277.24 81.79 2.36 1.34 0.99
u1=u2=0.2
327.99
0.00
279.76
2.78
0.04
2.69
model
Ψu
ΨI
Ψ



no treatment 467.97 467.97
u1=0.2,u2=0 7.30 229.11 236.41
u1=0,u2=0.2 7.30 375.67 382.97
u1=u2=0.2 14.6 116.44 131.04